Company intelligence / Profile preview
Sunhawk Vision Biotech, Inc.
Kaohsiung City, Taiwansunhawkvision.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Phase 2
01
Overview
Sunhawk Vision Biotech, founded in Taiwan in August 2019, develops novel nucleic acid drugs—specifically microRNA-based therapies—for ophthalmic diseases. Its lead product SHJ002 targets miR‐328 and has completed Phase I and II clinical trials for pediatric myopia and dry eye disease respectively. The company reported positive safety/tolerability data from its first-in-human trial and significant efficacy results from its Phase II trial in dry eye disease. Additional programs are underway targeting corneal damage/Sjogren’s syndrome and other ocular surface disorders. The company merged with Dreamhawk Vision Biotech in early February of 2024 to consolidate R&D efforts.
- Therapeutic areas
- Ophthalmology
- Modalities
- microRNA therapy (miRNA-based therapeutics)Antisense oligonucleotides
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
International pharmaceutical companies are actively seeking licensing deals for SHJ002; specific partners not named yet.
Beyond the preview
Go deeper on Sunhawk Vision Biotech, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sunhawk Vision Biotech, Inc..